Mortality in dialysis patients may not be associated with ESA dose: a 2-year prospective observational study

BACKGROUND: Anaemia of chronic kidney disease increases the risk of death and adverse events, but can be managed using erythropoiesis stimulating agents (ESAs). However, recent evidence suggests that targeting a higher haemoglobin concentration ([Hb]) increases mortality risk, and both higher [Hb] t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: McMahon, Lawrence P, Cai, Michael X, Baweja, Sanjeev, Holt, Stephen G, Kent, Annette B, Perkovic, Vlado, Leikis, Murray J, Becker, Gavin J
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3468396/
https://ncbi.nlm.nih.gov/pubmed/22702540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-13-40
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados